Skip to main content
main-content

Cardiology

Cardiology

18-09-2017 | Rheumatology | News | Article

RA disease activity and severity play ‘important role’ in reducing CVD risk

Targeting factors such as inflammation and disease activity in patients with rheumatoid arthritis could help reduce their risk for cardiovascular disease, study findings suggest.

30-08-2017 | Rheumatology | News | Article

Ibuprofen associated with elevated blood pressure in patients with arthritis

Patients with osteoarthritis or rheumatoid arthritis who take ibuprofen are more likely to experience an increase in systolic blood pressure than those taking celecoxib, results of the PRECISION-ABPM study suggest.

28-07-2017 | Oncology | News | Article

Statin eligibility points to increased cancer risk

Individuals eligible for statins according to the 2013 American College of Cardiology/American Heart Association guidelines have a significantly increased risk for developing or dying of cancer compared with noneligible individuals, US researchers report.

30-06-2017 | Rheumatology | News | Article

Low disease activity reduces RA-associated CVD risk

Low disease activity could delay the time to first cardiovascular disease event in patients with rheumatoid arthritis.

19-04-2017 | Rheumatology | News | Article

Celecoxib linked to reduced GI bleeding risk in patients with arthritis, cardiothrombotic disease

Results of the CONCERN trial suggest that celecoxib is associated with a lower risk for recurrent upper gastrointestinal bleeding than naproxen among patients with arthritis and cardiothrombotic diseases treated concomitantly with aspirin and non-steroidal anti-inflammatory drugs.

07-03-2017 | Public health | Highlight | Article

Diet associated with ‘substantial proportion’ of cardiometabolic deaths

Research published in JAMA suggests that suboptimal intake of specific dietary factors is associated with almost half of deaths from heart disease, stroke, or type 2 diabetes in the USA.

06-03-2017 | Pulmonary hypertension | News | Article

Systemic sclerosis associated with poor survival in CTD-PAH

A Chinese cohort study identifies factors associated with prognosis among patients with connective tissue disease-associated pulmonary arterial hypertension.

03-03-2017 | Interventional cardiology | News | Article

No benefit of ischemic postconditioning during PCI

Results of the DANAMI-3–iPOST trial suggest that ischemic postconditioning during percutaneous coronary intervention does not improve clinical outcome for patients with ST-segment elevation myocardial infarction.

03-03-2017 | Pulmonary hypertension | News | Article

Right atrial strain associated with clinical outcomes in PAH

Study results suggest that right atrial strain could predict adverse outcomes among patients with pulmonary arterial hypertension.

02-03-2017 | Interventional cardiology | News | Article

Benefits of complete versus target-only revascularization examined in multivessel CAD

Results of a meta-analysis suggest that complete revascularization is associated with a reduced risk for cardiac events, but not overall mortality, among patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

01-03-2017 | Arrhythmia | News | Article

No reduction in AF recurrence with aggressive blood pressure treatment

Reducing target blood pressure does not decrease the incidence of recurrent arrhythmia among patients undergoing catheter ablation for atrial fibrillation, results of a randomized trial suggest.

24-02-2017 | Cardiology | News | Article

No reduction in intraoperative bleeding with fibrinogen concentrate

Results of a randomized trial published in JAMA suggest that infusion of fibrinogen concentrate does not reduce intraoperative blood loss during high-risk cardiac surgery.

23-02-2017 | Cardiology | News | Article

Mediterranean diet may improve HDL atheroprotective functions

Adherence to a traditional Mediterranean diet could improve the atheroprotective functions of high-density lipoprotein among people with high cardiovascular risk, results from a substudy of the PREDIMED trial suggest.

21-02-2017 | Interventional cardiology | News | Article

Transradial CTO PCI may be feasible for noncomplex cases

Transradial percutaneous coronary intervention could be feasible for the treatment of noncomplex chronic total occlusions, but complex cases may require a transfemoral approach, Japanese researchers report.

17-02-2017 | Interventional cardiology | News | Article

Similar outcomes with BMS and DES in myocardial infarction with cardiogenic shock

Study results suggest that patients with acute myocardial infarction complicated by cardiogenic shock have similar outcomes when treated with drug-eluting or bare metal stents.

16-02-2017 | Arrhythmia | Main feed | Article

Real-world effectiveness, safety of novel oral anticoagulants in AF explored

A Danish nationwide cohort study published in The BMJ examines the effectiveness and safety profiles of novel oral anticoagulants among patients with atrial fibrillation.

15-02-2017 | Heart failure | News | Article

Elevated hs-cTnT levels could indicate subclinical cardiac disease

Minor increases in high-sensitivity cardiac troponin T levels may represent an early biochemical signature of subclinical heart disease, researchers report.

13-02-2017 | Hypertension | News | Article

Quarter-dose quadpill a promising antihypertensive approach

A pilot randomized crossover trial suggests that giving patients a single pill composed of four antihypertensives at a quarter of their usual dose is a promising means of controlling blood pressure.

10-02-2017 | Interventional cardiology | Highlight | Article

Steady long-term risk of late events with first-generation DES

Patients with first-generation drug-eluting coronary stents remain at risk for late adverse events, say researchers who report the 10-year outcomes of the Danish all-comer SORT OUT II trial.

08-02-2017 | Stroke | Highlight | Article

Prolonged ECG monitoring improves post-stroke atrial fibrillation detection

Research suggests that all patients aged 60 years or older who have had a stroke, irrespective of the suspected cause, could benefit from enhanced and prolonged monitoring for atrial fibrillation.

Image Credits